Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Novel Programmable DNA Nanosystem Designed for Low Cost Molecular Detection

By LabMedica International staff writers
Posted on 05 Jul 2016
Based in a novel way on the self-assembly forces between DNA complementary strands, researcher have developed programmable nanosystem that has now been applied in a proof-of-principle study on Ebola virus diagnosis potential.

The nanomachine is based on “the magic of how DNA works,” said Erik R. More...
Henderson, professor, Iowa State University (Ames, IO, USA). Prof. Henderson and former student Dr. Divita Mathur developed the system and its first application: genetic detection of Ebola virus. Such a machine would prove valuable in the developing world, where access to diagnostic medical equipment can be rare. This nanotechnology could be fabricated cheaply and deployed easily. In conjunction with a smartphone app, it could be used independently of traditional medical facilities to detect Ebola or other pathogens and diseases.

The trick lies in understanding the rules that govern how DNA works, said Prof. Henderson, “It’s possible to exploit that rule set in a way that creates advantages for medicine and biotechnology.” The researchers harnessed DNA hybridization forces so that the components of the nanomachines, once added to water and then heated and cooled, find each other and assemble correctly without further effort from the individual deploying the machines.

More technically, they harnessed the difference in persistence length (“rigidity”) of single-stranded and double-stranded DNA to elicit a defined physical state change in a self-assembling DNA nanosystem, a platform they call OPTIMuS (Oligo-Propelled Technology for Interrogating Molecular Systems). This inducible state change can be used to interrogate user-programmed molecular interactions within OPTIMuS. In this study they showed how OPTIMuS can be used to detect a soluble target molecule and assess the relative strength of a non-covalent (base stacking) molecular interaction. They employed an embedded photonic system that tests for the presence of the target molecules, where upon detection the photonic system flashes a light, which can be read with a fluorometer.

This sort of technology could be modified to detect other pathogens and other kinds of molecules. Prof. Henderson also envisions development of similar nanomachines that would encapsulate medication for targeted delivery.

The study, by Mathur D & Henderson ER, was published online June 7, 2016, in the journal Scientific Reports.

Related Links:
Iowa State University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.